Skip to main content
NIH funding notice PAR-19-113

Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)

Closed on January 7, 2022.

Posted
December 17, 2018
Close date
January 7, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

10 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $5,010,874 in first-year total cost, median $492,180.

Most frequent study sections

  1. Tumor Microenvironment Study Section[TME]4
  2. Cellular and Molecular Technologies Study Section[CMT]3
  3. Biomaterials and Biointerfaces Study Section[BMBI]1
  4. Developmental Therapeutics Study Section[DT]1
  5. Special Emphasis Panel[ZRG1 OTC-M (08)]1

Most frequent institutions

  1. AUBURN UNIVERSITY AT AUBURN1
  2. UNIVERSITY OF ARIZONA1
  3. UNIVERSITY OF CALIFORNIA LOS ANGELES1
  4. UNIVERSITY OF CHICAGO1
  5. UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN1
Competing awards under PAR-19-113 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2022Engineered Colon Cancer Tissue to Examine the Role of the Obese Microenvironment in Tumor Aggressiveness1R01CA267170-01A1GREENE, MICHAEL WLIPKE, ELIZABETH AAUBURN UNIVERSITY AT AUBURN, AL$500,160CMT
2021A microengineered colon cancer-chip designed to investigate tumor-stromal interactions driving cancer progression1R01CA241137-01A1MUMENTHALER, SHANNON MICHELLEUNIVERSITY OF SOUTHERN CALIFORNIA, CA$875,151TME
2021Perivascular tissue models to overcome MGMT-mediated temozolomide resistance in glioblastoma1R01CA256481-01HARLEY, BRENDAN A.UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN, IL$770,432CMT
2021Bioengineered Prostate-on Chip: Mechanisms of Stromal Dysregulation in Prostate Cancer1R01CA254200-01A1MIRANTI, CYNTHIA KZOHAR, YITSHAKUNIVERSITY OF ARIZONA, AZ$484,200TME
2021Probing cellular, molecular and biomechanical barriers to immunotherapy in the tumor microenvironment with organotypic in vitro models of the tumor-lympho-immune interface1R01CA253248-01A1SWARTZ, MELODY ANNUNIVERSITY OF CHICAGO, IL$433,439ZRG1
2021Enabling Technology to Study Mechanosensitive and Mechanoresistant Cancer Cells in Flow1R01CA256054-01A1KING, MICHAEL R.VANDERBILT UNIVERSITY, TN$297,905BMBI
2020Ex vivo analysis of human brain tumor cells in a microvascular niche model1R01CA245313-01FAN, RONGZHOU, JIANGBINGYALE UNIVERSITY, CT$556,102CMT
20203-Dimensional Retinal Organoid Platform for the Study of Retinoblastoma1R01CA248890-01HARBOUR, JAMES WILLIAMPELAEZ, DANIELUNIVERSITY OF MIAMI SCHOOL OF MEDICINE, FL$509,620TME
2020Tissue-Engineered Models of Microvessel-Mediated Glioblastoma Invasion1R01CA241927-01A1SEIDLITS, STEPHANIE KRISTINUNIVERSITY OF CALIFORNIA LOS ANGELES, CA$339,969TME
2020Engineered microtumor arrays for development of combination therapies1R01CA251443-01COPLAND, JOHN A.KILIAN, KRISTOPHER ALANUNIVERSITY OF NEW SOUTH WALES$243,896DT

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.